These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34670681)

  • 21. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.
    Chalmers JD; Taylor JK; Singanayagam A; Fleming GB; Akram AR; Mandal P; Choudhury G; Hill AT
    Clin Infect Dis; 2011 Jul; 53(2):107-13. PubMed ID: 21690616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia.
    Wang PH; Wang HC
    BMC Infect Dis; 2016 Aug; 16():377. PubMed ID: 27502599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.
    Amati F; Bindo F; Stainer A; Gramegna A; Mantero M; Nigro M; Bussini L; Bartoletti M; Blasi F; Aliberti S
    Adv Respir Med; 2023 May; 91(3):224-238. PubMed ID: 37366804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study.
    De Angelis G; Restuccia G; Venturiello S; Cauda R; Malhotra-Kumar S; Goossens H; Schrenzel J; Tacconelli E
    BMC Infect Dis; 2012 Mar; 12():74. PubMed ID: 22458427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome.
    Micek ST; Reichley RM; Kollef MH
    Medicine (Baltimore); 2011 Nov; 90(6):390-395. PubMed ID: 22033455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.
    Jones BE; Brown KA; Jones MM; Huttner BD; Greene T; Sauer BC; Madaras-Kelly K; Rubin MA; Bidwell Goetz M; Samore MH
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):937-944. PubMed ID: 28633678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
    Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
    Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 29. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
    Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
    Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.
    Vallés J; Martin-Loeches I; Torres A; Diaz E; Seijas I; López MJ; Garro P; Castillo C; Garnacho-Montero J; Martin Mdel M; de la Torre MV; Olaechea P; Cilloniz C; Almirall J; García F; Jiménez R; Seoane E; Soriano C; Mesalles E; Posada P
    Intensive Care Med; 2014 Apr; 40(4):572-81. PubMed ID: 24638939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
    Garcia-Vidal C; Viasus D; Roset A; Adamuz J; Verdaguer R; Dorca J; Gudiol F; Carratalà J
    Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.
    Chalmers JD; Rother C; Salih W; Ewig S
    Clin Infect Dis; 2014 Feb; 58(3):330-9. PubMed ID: 24270053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Challenging Diagnosis of Non-Community-Acquired Pneumonia in Non-Mechanically Ventilated Subjects: Value of Microbiological Investigation.
    Messika J; Stoclin A; Bouvard E; Fulgencio JP; Ridel C; Muresan IP; Boffa JJ; Bachmeyer C; Denis M; Gounant V; Esteso A; Loi V; Verdet C; Prigent H; Parrot A; Fartoukh M
    Respir Care; 2016 Feb; 61(2):225-34. PubMed ID: 26647452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the important risk factors for healthcare-associated pneumonia?
    Poch DS; Ost DE
    Semin Respir Crit Care Med; 2009 Feb; 30(1):26-35. PubMed ID: 19199184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon.
    Matta R; Hallit S; Hallit R; Bawab W; Rogues AM; Salameh P
    J Infect Public Health; 2018; 11(3):405-411. PubMed ID: 28970096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study.
    Torre-Cisneros J; Natera C; Mesa F; Trikic M; Rodríguez-Baño J
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):51-56. PubMed ID: 28887643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.
    Metersky ML; Frei CR; Mortensen EM
    Respirology; 2016 Jan; 21(1):157-63. PubMed ID: 26682638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.